5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide

C22H21N3O2 — CID 166681295

IUPAC5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide
SMILESNC(=O)c1cc(-c2ccccc2)ccc1N1CC[C@H](Oc2ccccn2)C1
InChIInChI=1S/C22H21N3O2/c23-22(26)19-14-17(16-6-2-1-3-7-16)9-10-20(19)25-13-11-18(15-25)27-21-8-4-5-12-24-21/h1-10,12,14,18H,11,13,15H2,(H2,23,26)/t18-/m0/s1
InChIKeyHTBDUQYLPUXEMT-SFHVURJKSA-N
MW359.43 g/mol
LogP3.51
Rot. Bonds5

About 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide

5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide (PubChem CID 166681295) has the molecular formula C22H21N3O2 and a molecular weight of 359.43 g/mol. Its IUPAC name is 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide.

Molecular Properties

Compound Name5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide
PubChem CID166681295
Molecular FormulaC22H21N3O2
Molecular Weight359.43 g/mol
Exact Mass359.16
IUPAC Name5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide
SMILESNC(=O)c1cc(-c2ccccc2)ccc1N1CC[C@H](Oc2ccccn2)C1
InChIInChI=1S/C22H21N3O2/c23-22(26)19-14-17(16-6-2-1-3-7-16)9-10-20(19)25-13-11-18(15-25)27-21-8-4-5-12-24-21/h1-10,12,14,18H,11,13,15H2,(H2,23,26)/t18-/m0/s1
InChIKeyHTBDUQYLPUXEMT-SFHVURJKSA-N
XLogP3.51
TPSA68.45 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500359.43
LogP ≤ 53.51
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(2S,3R)-2-methyl-3-(pyridin-2-yloxymethyl)piperidin-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
CID 58488153
5-[2-[2-(2-Ethylphenoxy)ethylamino]propyl]-1-(3-hydroxypropyl)indole-7-carboxamide
CID 123387804
[(2R,5R)-5-methyl-2-[(3-methyl-2-pyridinyl)oxymethyl]morpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
CID 46205522
6-[4-[(2-Phenyl-1-pyrrolidinyl)methyl]phenoxy]-3-pyridinecarboxamide
CID 56851423
US9546152, example 29
CID 74222492
5-[[3-[(4-Pyrrolidin-1-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide
CID 124156314
5-[[3-[(3-Methylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide
CID 124156466
5-[[3-[(4-Pyrrol-1-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide
CID 124156886
1-[(4-Methoxyphenyl)methyl]-5-pyridin-4-ylindole-2,3-dione
CID 141372273
2-ethoxy-N-[4-[(4-methoxyphenyl)carbamoyl]phenyl]pyridine-3-carboxamide
CID 2511800
2-[(4-prop-2-enoxybenzoyl)amino]-N-(pyridin-3-ylmethyl)benzamide
CID 6471437
2-{[(2-tert-butylphenoxy)acetyl]amino}-N-(pyridin-3-ylmethyl)benzamide
CID 6500005

Frequently Asked Questions

What is the IUPAC name of 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide?
The IUPAC name of 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide (CID 166681295) is 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide.
What is the SMILES notation for 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide?
The canonical SMILES for 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide is NC(=O)c1cc(-c2ccccc2)ccc1N1CC[C@H](Oc2ccccn2)C1.
What is the InChIKey of 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide?
The InChIKey is HTBDUQYLPUXEMT-SFHVURJKSA-N. The full InChI is InChI=1S/C22H21N3O2/c23-22(26)19-14-17(16-6-2-1-3-7-16)9-10-20(19)25-13-11-18(15-25)27-21-8-4-5-12-24-21/h1-10,12,14,18H,11,13,15H2,(H2,23,26)/t18-/m0/s1.
What are the key properties of 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide?
5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide has a molecular weight of 359.43 g/mol, XLogP of 3.51, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 5-phenyl-2-[(3S)-3-pyridin-2-yloxypyrrolidin-1-yl]benzamide is sourced from PubChem (CID 166681295), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).